Navigation Links
Bone cells' branches sense stimulation, when to make new bone
Date:7/20/2010

SAN ANTONIO (July 20, 2010) A long-standing question in bone biology has been answered: It is the spindly extensions of bone cells that sense mechanical stimulation and signal the release of bone-growth factors, according to research from The University of Texas Health Science Center at San Antonio.

The study, reported this week in Proceedings of the National Academy of Sciences of the United States of America, offers an important clue for developing therapies to treat the bone-thinning disease osteoporosis and bone loss associated with aging, said Jean Jiang, Ph.D., senior corresponding author from the Department of Biochemistry, UT Health Science Center Graduate School of Biomedical Sciences.

Sensitive extensions

"Osteocytes are the most abundant cells in bone," Dr. Jiang said. "In the field of bone biology, there was a long-standing debate as to which part of the osteocyte senses mechanical loading. In this study, we demonstrate for the first time that it is the extensions, which are called dendrites."

Regular physical exercise is highly beneficial in maintaining bone health and in prevention of bone loss and osteoporosis. Mechanical stimulation of the bone through weight bearing is critical for promoting bone remodeling, said Sirisha Burra, Ph.D., lead author from the Department of Biochemistry.

"Maintenance of bone health depends on the osteocytes' ability to sense the stimulation," Dr. Burra said. "If osteocytes lose this ability, it could possibly lead to diseases such as osteoporosis. Hence, it is important to understand this mechanism."

Mechanical impact

The Health Science Center collaborated with Southwest Research Institute in San Antonio to estimate the mechanical impact of force applied to the dendrites. Magnitudes of mechanical stress were determined.

"Understanding how bone cells sense and respond to mechanical signals within the skeleton is an inhere
'/>"/>

Contact: Will Sansom
sansom@uthscsa.edu
210-567-2579
University of Texas Health Science Center at San Antonio
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Breast cancer cells regulate multiple genes in response to estrogen-like compounds
2. UCLA scientists create army of tumor-fighting immune cells and watch as they attack cancer
3. New E-Commerce Website for Spectroscopy Cuvettes and Other Precise Optical Products Launched by NSG Precision Cells
4. Scientists reprogram triple-negative breast cancer cells to respond to tamoxifen
5. CELLING Treatment Centers New Clinic Revolutionizes Spinal Care with Adult Stem Cells
6. Fat cells play key role in development of type 2 diabetes
7. Researchers identify factors behind blood-making stem cells
8. Cancer stem cells are not 1 size fits all, lung cancer models show
9. Study shows how dietary supplement may block cancer cells
10. Chromosomal variations found in early passage female embryonic stem cells
11. Fructose sugar makes maturing human fat cells fatter, less insulin-sensitive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... 2013 Minor fender benders and serious ... require parties to the accident to respond appropriately to ... and Prevention (CDC) data from 2010, accidents, including car ... In fact, in 2005, automobile accident-related deaths ... more than 2.3 million drivers and passengers receive treatment ...
(Date:5/19/2013)... Columbus, OH (PRWEB) May 19, 2013 ... LLC continue to follow developments in the nation’s first ... The case, underway in Washington State Superior Court, was ... several years after he suffered complications in a robot-assisted ... The Da Vinci robotic surgery lawsuit ...
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
(Date:5/18/2013)... 19, 2013 The American Society for Gastrointestinal Endoscopy ... endoscopy during the ninth annual ASGE Crystal Awards on ... ASGE Foundation, this year,s event will begin at ... Fla. , Held in conjunction with Digestive Disease ... in leadership, research and scientific pursuit. The event will ...
(Date:5/18/2013)... Bethesda, MD (May 19, 2013) The American ... announce its 2013 research scholars. This year,s honorees ... in gastroenterology, hepatology or related areas, and with ... , "These young researchers are the future ... young scholars who are paving the way for ...
Breaking Medicine News(10 mins):Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7Health News:AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists 2
... a specialty,bank consulting firm, has moved its affiliation to ... independent office of,John Hancock Financial Network in Buffalo, NY, ... to the entire network nationally,announced Peter Gordon, President of ... are excited to be able to offer this specialized ...
... In a statewide survey of medical professionals, 38 physician-scientists ... Medical Center (LA BioMed) are honored for being ... issue of Los Angeles magazine. , Key Professional Media, ... professionals to compile the 2008 list of Southern California ...
... of West,Virginia, Inc. and the Nitro Walmart Marketplace are working ... significant,increase for unexpected emergency needs assistance. , ... events, being held this Friday and,Saturday, more than $20,000 in ... food that will help thousands of area families pay bills, ...
... Clinically Proven, Anti-Aging REVALESKIN(R) Skin Care Brand Launches ... and REVALESKIN(R) Chest/Decolletage Rejuvenating Treatment, All Exclusively Formulated ... , CORAL GABLES, ... of the extraordinarily successful introduction of the core ...
... , , NEW YORK, Dec. 4 ... that it has repurchased 640,930 shares of WebMD Class A Common ... LLC, which was acquired by WebMD in December 2006. In ... in cash pursuant to the terms of the previously completed Subimo ...
... Dec. 4 The Perrigo Company,(Nasdaq: PRGO ... Desloratadine tablets (5 mg) has been settled with Perrigo ... been sued for patent infringement of,US Patent Nos. 6100274, ... ANDA,containing a Paragraph IV certification. Under the terms ...
Cached Medicine News:Health News:John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally 2Health News:John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally 3Health News:LA BioMed researchers among Southern California Super Doctors 2Health News:UniCare, Walmart Organize Circle of Hope To Help Mountain Mission Meet Increased Demand for Assistance 2Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 2Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 3Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 4Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 5Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 6Health News:WebMD Announces Repurchase of 640,930 of its Shares 2Health News:Perrigo Settles Desloratadine Patent Litigation 2Health News:Perrigo Settles Desloratadine Patent Litigation 3
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Patients with active moderate to severe rheumatoid arthritis ... or adalimumab (Humira ® ) and who were actively ... from baseline at week 10, and sustained response through ... 26 results from the RESTART study were presented for ...
... LLC, the image analysis and pattern recognition technology provider, ... of $244,479.25 under the U.S. Government,s Affordable Care Act. ... projects that show significant potential to produce new therapies, ... health care costs or advance the goal of curing ...
Cached Medicine Technology:New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 2New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 3New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 4New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 5New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 6New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 7Parascript Awarded $244,479.25 Affordable Care Act Grant From the U.S. Government 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: